EN
登录

医疗保健SaaS平台开发商Synthpop筹集1500万美元A轮融资,以扩展使其医疗保健更人性化的AI技术

Synthpop Raises $15 Million Series A to Scale AI That Makes Healthcare More Human

vcaonline 等信源发布 2026-02-05 00:08

可切换为仅中文


Synthpop Raises $15 Million Series A to Scale AI That Makes Healthcare More Human

合成流行音乐公司筹集了1500万美元的A轮融资,以扩展使医疗保健更具人性化的AI技术。

Funding will accelerate automation of administrative workflows across the entire patient journey using multi-agent AI, helping providers focus on patient care

资金将加速在整个患者旅程中使用多智能体人工智能实现管理流程的自动化,帮助医疗服务提供者专注于患者护理。

CAMBRIDGE, Mass., February 4, 2026-- Synthpop, Inc., a healthcare AI company building agentic automation to eliminate administrative bottlenecks in payer, provider, and patient operations, announced today a $15 million Series A, bringing the company’s total funding to $23 million. The round was led by Ansa Capital, with Marco DeMeireles, Co‑Founder & Managing Partner at Ansa, joining Synthpop’s Board of Directors.

马萨诸塞州剑桥市,2026年2月4日——Synthpop公司是一家医疗保健人工智能公司,致力于构建代理自动化以消除支付方、服务提供方和患者运营中的行政瓶颈。该公司今天宣布完成了1500万美元的A轮融资,使得公司总融资额达到2300万美元。本轮融资由Ansa Capital领投,Ansa的联合创始人兼管理合伙人马可·德梅勒斯(Marco DeMeireles)将加入Synthpop董事会。

Defy.vc and Peterson Ventures participated in the round, alongside Storm Ventures and strategic investor Bruce Broussard..

Defy.vc 和 Peterson Ventures 参与了此轮融资,同时参与的还有 Storm Ventures 和战略投资者 Bruce Broussard。

Synthpop unifies document intelligence, payer-aware reasoning, and conversational voice agents into one coordinated system that automates up to 80% of healthcare business processes. These agents integrate directly with EHR, billing, and e-prescribe platforms, and customers use it to handle workflows that range from referrals, prior authorizations, eligibility checks, claims follow-ups, to patient access and more – reducing denials, saving costs, speeding up patient care, and lightening the overall administrative burden.

合成流行音乐将文档智能、支付者感知推理和会话语音代理整合到一个协调的系统中,该系统可以自动化高达80%的医疗保健业务流程。这些代理直接与电子健康记录(EHR)、计费和电子处方平台集成,客户使用它来处理从转诊、预先授权、资格检查、理赔跟进到患者访问等各类工作流程——减少拒绝,节省成本,加快患者护理速度,并减轻整体行政负担。

Over the past year, Synthpop has demonstrated significant traction, processing over 2 million patients and now integrating with 8 major EHR systems..

在过去的一年中,Synthpop 展现了显著的吸引力,处理了超过 200 万名患者,并且现在已与 8 个主要的电子健康记录(EHR)系统集成。

'Point solutions can't fix operational bottlenecks,' said Elad Ferber, CEO of Synthpop. 'Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software. This funding helps us expand our coverage and deepen integrations so providers can scale their operations and expand access to care.”.

“点解决方案无法解决运营瓶颈,”Synthpop首席执行官Elad Ferber表示。“供应商需要一个统一的系统,能够理解保险要求、自然处理电话,并与现有软件无缝协作。这笔资金将帮助我们扩展覆盖范围并深化集成,使供应商能够扩大运营规模并增加护理的可及性。”

Some of the nation’s largest organizations across DME, Fertility, Diagnostics, and more have already seen substantial benefits by adopting Synthpop. Workflows that historically took 40 minutes are now processed in <1 minute at a 5x lower cost than traditional human labor spend, while maintaining complete compliance and transparency..

一些跨DME、生育、诊断等领域的美国最大型机构,通过采用Synthpop已经获得了显著的效益。以往需要40分钟完成的工作流程,现在可以在不到1分钟内处理完毕,成本仅为传统人力投入的五分之一,同时完全保持合规性和透明度。

“Healthcare organizations have long been constrained by highly manual workflows and human capital bottlenecks. AI-native solutions like Synthpop are the only way for them to fulfill rising demand and increased patient expectations,” said Marco DeMeireles, Co‑Founder & Managing Partner at Ansa. “The early value delivered to customers has been extremely compelling; I’m thrilled to join the Board and partner with Elad and the Synthpop team.”.

“长期以来,医疗保健组织一直受限于高度手动的工作流程和人力资本的瓶颈。像Synthpop这样的原生AI解决方案是他们满足不断增长的需求和提高患者期望的唯一途径,”Ansa的联合创始人兼管理合伙人马可·德梅勒斯表示,“早期为客户带来的价值非常令人信服;我很高兴加入董事会,并与Elad和Synthpop团队合作。”

The funding news comes shortly after the airt team – led by Davor Runje and Hajdi Cenan – joined Synthpop to accelerate its AI workflow capabilities. Davor and Hajdi built FastStream and FastAgency, and made major contributions to AutoGen, Microsoft’s open-source framework for building agentic AI applications.

这笔资金的消息是在由达沃尔·伦杰和哈伊迪·切南领导的airt团队加入Synthpop后不久传出的,此举旨在加速其人工智能工作流程能力。达沃尔和哈伊迪构建了FastStream和FastAgency,并对微软的开源框架AutoGen做出了重要贡献,该框架用于构建代理型人工智能应用程序。

Synthpop will use this round of funding to continue expanding the team, deepen their product capabilities, and further expand into additional healthcare verticals.

合成流行音乐公司将利用此轮融资继续扩大团队,深化产品能力,并进一步扩展到更多的医疗垂直领域。

“Synthpop stood out to us for its ability to automate complex, real-world healthcare workflows with speed, accuracy, and compliance,” said Medha Agarwal, General Partner at Defy.vc. “We’ve been impressed by their progress as investors, and we’re excited to double down. Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey.

“Synthpop以其能够快速、准确且合规地自动化复杂的现实世界医疗工作流程而脱颖而出,”Defy.vc的普通合伙人Medha Agarwal表示。“作为投资者,他们的进展给我们留下了深刻印象,我们很高兴加倍投入。他们的多代理平台为医疗服务提供者带来了即时且可衡量的价值,大幅减少了患者旅程中的时间、成本和摩擦。”

With strong customer adoption and a world-class technical team, we believe Synthpop is building critical infrastructure for a more efficient, human-centered healthcare system, and we’re excited to support a mission that ultimately helps speed up and improve access to care for patients.”.

“凭借强大的客户采用率和世界级的技术团队,我们相信Synthpop正在为更高效、以人为本的医疗系统构建关键基础设施,我们非常支持这一最终帮助加速和改善患者获得医疗服务的使命。”

To get in touch with the Synthpop team, reach out at https://www.synthpop.ai/contact-us.

要与合成流行团队联系,请访问 https://www.synthpop.ai/contact-us。

About Synthpop

关于合成器流行音乐

Synthpop is an API‑first, multi‑agent system for healthcare operations. By combining document intelligence, payer‑aware reasoning, conversational voice agents, and an orchestration layer, Synthpop eliminates administrative friction across referrals, prior authorizations, eligibility, documentation, and claims..

Synthpop 是一个以 API 为先导的多代理系统,用于医疗保健运营。通过结合文档智能、支付方感知推理、对话语音代理和编排层,Synthpop 消除了转诊、事先授权、资格认证、文档和索赔等环节的行政摩擦。

Founded in 2023 by Elad Ferber (CEO) and Jan Jannink, PhD (CTO), the company brings together healthcare entrepreneurship and deep AI infrastructure expertise. Elad previously co-founded Spry Health and led it through acquisition by ZOLL Itamar. Jan co-founded imeem and VoiceBase, and teaches AI and scalable systems at Stanford..

公司成立于2023年,由埃拉德·费尔伯(Elad Ferber,首席执行官)和扬·詹尼克博士(Jan Jannink,首席技术官)共同创立,融合了医疗保健创业和深度人工智能基础设施的专业知识。埃拉德曾共同创立Spry Health,并带领公司被ZOLL Itamar收购。扬曾共同创立imeem和VoiceBase,同时在斯坦福大学教授人工智能和可扩展系统。

Synthpop is SOC 2‑audited and fully HIPAA compliant. Learn more at synthpop.ai.

Synthpop 已通过 SOC 2 审计,并完全符合 HIPAA 标准。更多信息请访问 synthpop.ai。

About Ansa Capital

关于安萨资本

Ansa is a venture capital firm founded by Marco DeMeireles and Allan Jean-Baptiste focused on creating a new model for founders: equal, aligned, and relentless. Backed by leading US institutions, we leverage our experience as early partners to companies like CrowdStrike, Coinbase, Zscaler, and Peloton to support our operators’ evolution into category definers.

安萨是一家由马可·德梅勒斯和艾伦·让-巴蒂斯特创立的风险投资公司,专注于为创始人打造一个全新的模式:平等、一致且不懈努力。我们得到美国领先机构的支持,凭借早期与CrowdStrike、Coinbase、Zscaler和Peloton等公司合作的经验,助力我们的运营者成长为行业定义者。

Our commitment goes beyond capital — our network of advisors aids our visionary founders in operational scaling, and our Revenue Council of experienced go-to-market leaders share in our mission to equip the teams we back with indispensable tools that accelerate their path to market leadership. To learn more about Ansa, visit: https://ansa.co..

我们的承诺超越了资本——我们的顾问网络帮助有远见的创始人进行运营扩展,我们的收入委员会由经验丰富的上市领导者组成,他们与我们使命一致,为支持的团队提供不可或缺的工具,加速他们通往市场领导地位的道路。欲了解有关Ansa的更多信息,请访问:https://ansa.co。

About Defy

关于Defy

Founded in 2016, defy.vc is a Silicon Valley based early stage venture capital firm. Defy was founded to invest in entrepreneurs and companies looking to solve complex problems. Defy's focus is to help early stage companies mature and scale into companies ready for growth capital. The firm's team has more than 50 years of venture experience, successful entrepreneurial and operating backgrounds, and actively helps founders grow companies from inception through exit.

Defy.vc 成立于2016年,是一家位于硅谷的早期风险投资公司。Defy 的宗旨是投资那些致力于解决复杂问题的企业家和公司。Defy 专注于帮助早期阶段的公司成熟并扩展为准备好接受增长资本的企业。该公司的团队拥有超过50年的风险投资经验、成功的创业和运营背景,并积极帮助创始人从公司创立到退出的整个成长过程。

Connect with defy.vc at https://defy.vc/ and @defyvc..

通过 https://defy.vc/ 和 @defyvc 与 defy.vc 联系。

About Peterson Ventures

关于彼得森风险投资公司

Peterson Ventures is a founder-first pre-Series A venture fund that invests across SaaS and Digital Commerce including e-commerce, fintech, and healthtech. Peterson Ventures is the ten-year-old venture arm of the Peterson Partners platform, an independent investment management firm founded by Joel Peterson with over $1.8B AUM.

彼得森创投是一家以创始人为优先的预A轮风险投资基金,专注于投资SaaS和数字商务领域,包括电子商务、金融科技和健康科技。彼得森创投是彼得森合作伙伴平台旗下拥有十年历史的风险投资部门,该平台是由乔尔·彼得森创立的一家独立投资管理公司,管理资产超过18亿美元。

Peterson Ventures is run by Managing Director Ben Capell and General Partner Ilana Stern..

彼得森风险投资公司由董事总经理本·卡佩尔和普通合伙人伊兰娜·斯特恩经营。

About Storm Ventures

关于Storm Ventures

Storm Ventures is an early-stage B2B focused venture firm. With over 23 years of experience and 200+ investments, Storm has successfully worked with many founders across the globe in navigating the journey from inception to $100 million in ARR.

Storm Ventures是一家专注于B2B的早期风险投资公司。凭借超过23年的经验和200多项投资,Storm已成功与全球众多创始人合作,帮助他们从初创阶段发展到实现1亿美元的年度经常性收入(ARR)。

Contact:

联系:

Media

媒体

Hajdi Cenan

哈吉·切南

hajdi@synthpop.ai

hajdi@synthpop.ai